Covance Clinical Research Inc

Daytona Beach, Florida 32117

0 studies enrolling now · 27 studies all time

What they study most

Alzheimer Disease, Dyslipidemia, Dyslipidemias, Healthy, Healthy Volunteers

Studies at this site

A Study of LY3463251 in Healthy Participants — Stopped early
A Study of LY3522348 in Healthy Participants — Completed
A Drug Drug Interaction (DDI) Study of Selpercatinib and Dabigatran in Healthy Participants — Completed
A Study of Injections of LY3074828 in Healthy Participants — Completed
A Study of Mirikizumab in Healthy Participants — Completed
A Study of Two Formulations of LY3074828 in Healthy Participants — Completed
A Study of Tirzepatide at Different Injection Sites in Participants With Different Body Sizes — Completed
A Study of Ramucirumab (LY3009806) in Healthy Participants — Completed
A Study of Two Formulations of Ixekizumab in Healthy Participants — Completed
A Study of LY3832479 (LY-CoV016) in Healthy Participants — Completed
A Study of LY3832479 (LY-CoV016) in Healthy Participants 1 — Completed
A Study of LY3819253 (LY-CoV555) in Healthy Participants — Completed
A Study of LY3475766 in Healthy Participants — Completed
A Study of LY3461767 in Healthy Participants — Completed
A Study of LY2623091 in Healthy Participants — Completed
A Study of Ixekizumab in Healthy Participants — Completed
A Drug Interaction Study of LY3154207 in Healthy Participants — Completed
A Study of Lasmiditan on Simulated Driving Performance in Healthy Participants — Completed
A Study of Lasmiditan in Healthy Elderly Participants — Completed
A Study of Lanabecestat (LY3314814) in Healthy Participants When Taken With Rosuvastatin — Completed
A Study of Different Injectable Formulations of LY3375880 in Healthy Participants — Completed
A Study of LY3372993 in Healthy Participants and Participants With Alzheimer's Disease (AD) — Completed
A Study of Galcanezumab in Healthy Participants. — Completed
An Interaction Study of LY3200882 in Healthy Participants — Completed
A Study of Evacetrapib in Participants With Abnormal Cholesterol — Completed
A Study of LY3023414 Formulations and the Effect of Food — Completed
A Study of Merestinib (LY2801653) in Healthy Participants — Completed